The Latest Cardiac and Vascular News
~ Strong start to the year with 1Q23 financial results ~ ~ Executing strategy to accelerate growth ~ PLANO, Texas, April 27, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended March 31, 2023. First Quarter 2023 Highlights (compared to First Quarter […]
WARRINGTON, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders of acute heart failure and a lead program studying istaroxime in cardiogenic shock. Cardiogenic shock is caused by a failing […]
New company name chosen to represent focus on ‘averting’ serious cardiac complications with state-of-the-art Guardian™ monitoring and alerting system President and CEO Tim Moran and Chief Financial Officer Philip Tom to join Executive Chairman Ross Haghighat in leadership roles EATONTOWN, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Angel Medical Systems […]
Ghent, Belgium, 27 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that in the context of the private placement of new shares and new subscription rights that was announced on 24 April 2023 and […]
Q1 2023 reported revenue of $297.6 million, up 8.0% compared to Q1 2022 Q1 2023 constant currency revenue, organic* up 9.8% compared to Q1 2022 Q1 2023 GAAP operating margin of 8.9%, compared to 5.5% in Q1 2022 Q1 2023 non-GAAP operating margin* of 16.1%, compared to 14.6% in Q1 […]
The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers – Clariscan (gadoteric acid) and Pixxoscan (gadobutrol) Pixxoscan has the same active substance (gadobutrol) and the same qualitative and quantitative composition as the reference product, Gadovist® The […]
Reports First Quarter Revenues of $11.3 Billion Posts First Quarter GAAP Earnings Per Share of $1.07 and Non-GAAP EPS of $2.05; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income Delivers Strong Revenue Growth of 8% from In-Line Products […]
MANHASSET, N.Y.–(BUSINESS WIRE)–It was a day of celebration and reflection as cardiac doctors, surgeons, nurses and therapists gathered at Sandra Atlas Bass Heart Hospital (SABHH) at North Shore University Hospital (NSUH) on April 26 to celebrate a medial milestone for the health system and region – more than 100 heart transplants have been performed […]
The Heartland Partnership Represents USHV’s First in Kansas. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced its partnership with Heartland Cardiology (“Heartland”), a Wichita-based cardiovascular physician practice focused on preventative care, diagnostic testing, curative procedures and electrophysiology services. With […]
First-quarter revenue of $3.65 billion decreased 2% on a reported basis and increased 2% on a constant currency basis1 First-quarter U.S. GAAP earnings per share (EPS) totaled $0.09; Adjusted EPS totaled $0.59 Baxter expects full-year 2023 sales growth of 1% to 2% on a reported basis and ~1% on a […]
